Applied UV to Present and Showcase Airocide and Scientific Air Technology at Hotel, Restaurant & Catering (HRC) 2022 in London
March 16 2022 - 7:45AM
Business Wire
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically,
announces that Keith Frein, the Company’s VP of International
Sales, will be presenting and showcasing the Company’s patented,
research backed Airocide and Scientific Air Management air
purification products at Hotels, Restaurants and Catering (HRC)
2022 in London, UK March 21-23, 2022.
Hotels, Restaurants & Catering is the UK’s largest and most
prestigious business event for hospitality and foodservice
professionals and is globally recognized as being at the forefront
of innovation and product excellence. Trusted and supported by FEA,
The Craft Guild of Chefs, The Caterer, The Staff Canteen, The
British Culinary Federation and the Association of Pastry Chefs,
the event is forecast to attract over 30,000 visitors of which 80%
have purchasing power. HRC’s 2020 event was attended by globally
recognized brands and decision makers from McDonalds, Hard Rock
Café, Pizza Hut, Hilton Hotels, Accor Hotels, NOBU Hotels and
Firmdale Hotels to name a few.
Keith Frein, Sterilumen’s VP of International Sales, stated,
“HRC is the most relevant hospitality show in Europe. As a leading
global supplier of air purification and surface disinfection suite
of products, we are excited to attend the conference and speak to
leaders of hospitality and restaurants about the potential benefits
of incorporating our products into their facilities as the world’s
economy re-opens from the throes of a three-year pandemic. History
is a great teacher, so as businesses move forward, incorporating
our suite of pathogen elimination products can protect guests,
employees and facilities from future business disruptions due to
the spread of airborne viruses.”
About Applied UV
Applied UV is focused on the development and acquisition of
technology that address infection control in the healthcare,
hospitality, commercial and municipal markets. The Company has two
wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and
Munn Works, LLC (“Munn Works”). SteriLumen’s connected platform for
Data Driven Disinfection™ applies the power of ultraviolet light
(UVC) to destroy pathogens safely, thoroughly, and automatically,
addressing the challenge of healthcare-acquired infections
("HAIs"). Targeted for use in facilities that have high customer
turnover such as hospitals, hotels, commercial facilities, and
other public spaces, the Company’s Lumicide™ platform uses UVC LEDs
in several patented designs for infection control in and around
high-traffic areas, including sinks and restrooms, killing
bacteria, viruses, and other pathogens residing on hard surfaces
within devices’ proximity. The Company’s patented in-drain
disinfection device, Lumicide Drain, is the only product on the
market that addresses this critical pathogen intensive location.
SteriLumen’s Airocide® air purification devices are research
backed, clinically proven, and developed for NASA with assistance
from the University of Wisconsin. Airocide® is listed as an FDA
Class II Medical device, utilizes a proprietary photocatalytic
(PCO) bioconversion technology that draws air into a reaction
chamber that converts damaging molds, microorganisms, dangerous
airborne pathogens, destructive VOCs, allergens, odors and
biological gasses into harmless water vapor and green carbon
dioxide without producing ozone or other harmful byproducts.
Airocide® applications include healthcare, hospitality, grocery
chains, wine making facilities, commercial real estate, schools,
dental offices, post-harvest, grocery, cannabis facilities and
homes. For more information about Applied UV, Inc., and its
subsidiaries, please visit the following websites:
https://www.applieduvinc.com/; https://sterilumen.com/;
https://www.airocide.com; https://kesscience.com;
https://scientificairmanagement.com; www.airoclean420.com, and
https://munnworks.com/.
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward‐looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward–looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward‐looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward‐looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward‐looking
statements to conform these statements to actual results.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220316005021/en/
Applied UV Inc. Max Munn Applied UV Interim CEO
max.munn@sterilumen.com
Brett Maas, Managing Principal Hayden IR brett@haydenir.com
(646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Sep 2023 to Sep 2024